Bank of America
OYST

Bank of America’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Bank of America’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,057
Closed -$124K – 8677
2022
Q4 		$124K Sell
11,057
-2,394
-18% -$23.2K ﹤0.01% 6151
2022
Q3 		$76K Sell
13,451
-3,419
-20% -$21.4K ﹤0.01% 6489
2022
Q2 		$73K Sell
16,870
-7,693
-31% -$43.7K ﹤0.01% 6646
2022
Q1 		$286K Sell
24,563
-3,737
-13% -$44.5K ﹤0.01% 6231
2021
Q4 		$517K Buy
28,300
+24,572
+659% +$312K ﹤0.01% 5830
2021
Q3 		$45K Sell
3,728
-474
-11% -$6.9K ﹤0.01% 7103
2021
Q2 		$72K Sell
4,202
-1,059
-20% -$20.1K ﹤0.01% 6675
2021
Q1 		$96K Buy
5,261
+592
+13% +$12.4K ﹤0.01% 6409
2020
Q4 		$88K Sell
4,669
-301
-6% -$6.49K ﹤0.01% 6052
2020
Q3 		$104K Buy
4,970
+977
+24% +$22.8K ﹤0.01% 5691
2020
Q2 		$115K Buy
3,993
+1,906
+91% +$57.4K ﹤0.01% 5605
2020
Q1 		$73K Buy
2,087
+1,152
+123% +$37.3K ﹤0.01% 5699
2019
Q4 		$23K Buy
+935
New +$16.4K ﹤0.01% 6475

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's OYST Position: Q1 2023 in Review

Bank of America sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 11,057 shares — an estimated $124K sold.

Bank of America first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $517K in Q4 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Bank of America reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 11,057 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $124K.
  • Bank of America first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • Bank of America's Oyster Point Pharma, Inc. Common Stock position peaked at $517K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.